Metabolic consequences of sleep-disordered breathing

Area of Science:

• Metabolic disorders
• Sleep medicine
• Cardiovascular disease risk factors

Background:

• Metabolic syndrome (MetS) is a cluster of conditions including obesity, insulin resistance, and hypertension, increasing cardiovascular risk.
• While excess caloric intake drives MetS, environmental and genetic factors, particularly sleep-disordered breathing, are implicated.
• Obstructive sleep apnea (OSA), characterized by intermittent hypoxia (IH), may induce or worsen MetS components.

Purpose of the Study:

• To explore the causal relationship between sleep-disordered breathing and metabolic dysfunction.
• To investigate the role of obstructive sleep apnea (OSA) in the development and exacerbation of metabolic syndrome (MetS).

Main Methods:

• Review of clinical studies on OSA's effects on glucose metabolism, lipids, inflammation, and liver disease.
• Utilizing animal models of OSA (rodent IH exposure) to isolate IH effects from confounding factors like obesity.
• Investigating IH-induced alterations in glucose homeostasis, carbohydrate uptake, lipid profiles, and cholesterol synthesis in animal models.

Main Results:

• Clinical studies indicate OSA impacts glucose metabolism, cholesterol, inflammation, and nonalcoholic fatty liver disease.
• Animal models demonstrate IH disrupts glucose homeostasis, impairs muscle glucose uptake, and alters lipid and cholesterol metabolism.
• Obesity and high-fat diets exacerbate insulin resistance and liver inflammation in IH models.

Conclusions:

• Intermittent hypoxia from OSA may contribute to MetS morbidity through inflammation and oxidative stress.
• Understanding OSA's role in MetS could significantly impact clinical management and understanding of both conditions.
• Further research into the mechanisms linking IH to metabolic dysfunction is warranted.